Mometasone Furoate

Overview

Mometasone Furoate is a synthetic corticosteroid with anti-inflammatory and antipruritic properties. It is commonly used in the treatment of skin conditions and allergic rhinitis.

API suppliers (24)

Suppliers of Mometasone Furoate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• ARCH PHARMALABS LTD4 active DMF
• CORAL DRUGS PVT LTD3 active DMF
• TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina2 active DMF
• NEWCHEM SPA2 active DMF
• SYMBIOTEC PHARMALAB PRIVATE LTD2 active DMF
• STERLING SPAItaly2 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael2 active DMF
• Cipla USA, Inc.USA2 active DMF
• TAPI NL BV1 active DMF
• TAPI NL BV1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• FARMABIOS SPA1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• Ono Pharmaceutical Co., Ltd.Japan1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• TAPI NL BV1 active DMF
• Ono Pharmaceutical Co., Ltd.Japan1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• FARMABIOS SPA1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF
• CURIA SPAIN SAUSpain1 active DMF
• HUNAN DONGTING PHARMACEUTICAL CO LTDChina

Patent & exclusivity (US)

Per the FDA Orange Book (20 approved US products), the latest listed US patent on Mometasone Furoate expires 24 Nov 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas